Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population. Methotrexate (MTX) reduces cardiovascular risk in patients with rheumatoid arthritis ...
With more than 120 researchers representing more than 16 countries around the world, and disciplines ranging from biomedical engineering to medicinal chemistry to fluorescence-guided surgery, our ...
Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback